Prescient Therapeutics (ASX:PTX) Total Assets: A$18.48 Mil (As of Dec. 2025)


What is Prescient Therapeutics Total Assets?

Prescient Therapeutics ASX:PTX +1.49% Total Assets is A$18.48 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Prescient Therapeutics's Total Assets for the quarter that ended in Dec. 2025 was A$18.48 Mil.

During the past 12 months, Prescient Therapeutics's average Total Assets Growth Rate was 6.60% per year. During the past 3 years, the average Total Assets Growth Rate was 12.70% per year. During the past 5 years, the average Total Assets Growth Rate was 9.50% per year. During the past 10 years, the average Total Assets Growth Rate was 5.70% per year.

During the past 13 years, Prescient Therapeutics's highest 3-Year average Total Assets Growth Rate was 388.60%. The lowest was -87.30%. And the median was 1.75%.

Total Assets is connected with ROA %. Prescient Therapeutics's annualized ROA % for the quarter that ended in Dec. 2025 was -48.26%. Total Assets is also linked to Revenue through Asset Turnover. Prescient Therapeutics's Asset Turnover for the quarter that ended in Dec. 2025 was 0.00.

Prescient Therapeutics  (ASX:PTX) Total Assets Explanation

Total Assets is connected with ROA %.

Prescient Therapeutics's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-7.974/( (14.562+18.481)/ 2 )
=-7.974/16.5215
=-48.26 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Prescient Therapeutics's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=0/( (14.562+18.481)/ 2 )
=0/16.5215
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Prescient Therapeutics Total Assets Related Terms

Prescient Therapeutics Total Assets Historical Data

* Premium members only.

The historical data trend for Prescient Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prescient Therapeutics Total Assets Chart

Prescient Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.97 17.62 28.11 20.39 14.56

Prescient Therapeutics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.76 20.39 16.58 14.56 18.48

Prescient Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Prescient Therapeutics's Total Assets for the fiscal year that ended in Jun. 2025 is calculated as

Total Assets=Total Equity (A: Jun. 2025 )+Total Liabilities (A: Jun. 2025 )
=11.387+3.174
=14.56

Prescient Therapeutics's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=16.972+1.51
=18.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of A$18.48 Mil mean?
Prescient Therapeutics (ASX:PTX) has a Total Assets of A$18.48 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Prescient Therapeutics and its competitors.
Is Prescient Therapeutics' Total Assets too high?
Prescient Therapeutics' current Total Assets is A$18.48 Mil.
How does Prescient Therapeutics' Total Assets compare to VRTX and REGN?
Prescient Therapeutics' Total Assets of A$18.48 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Prescient Therapeutics and its competitors. Prescient Therapeutics's current Total Assets is A$18.48 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prescient Therapeutics stock overvalued right now?
Prescient Therapeutics (ASX:PTX) has a current Total Assets of A$18.48 Mil. The current Total Assets is A$18.48 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Prescient Therapeutics (ASX:PTX), the current Total Assets is A$18.48 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Prescient Therapeutics Business Description

Address 385 Bourke Street, Suite 2, Level 11, Melbourne, VIC, AUS, 3200
Prescient Therapeutics Ltd is a clinical-stage oncology company. The company develops novel compounds for the treatment of a range of cancers in Australia. Its product in the pipeline includes OmniCAR; PTX-100 and PTX-200. OmniCAR is a universal immune receptor platform enabling controllable T-cell activity and multi-antigen targeting with a single cell product.